Finance
Zealand Pharma’s survodutide achieves 16.6% weight loss in trial
Zealand Pharma’s survodutide achieves 16.6% weight loss in trial
I
Investing.com
April 28, 2026·1 min read
GM
FinanceZealand Pharma’s survodutide achieves 16.6% weight loss in trial
Original article
Zealand Pharma’s survodutide achieves 16.6% weight loss in trial
Published by Investing.com